secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001156039-25-000056
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q1 2025 revenue $48.8B (+15.4% YoY); adj. diluted EPS $11.97; reaffirms FY guidance
--------------------------------------------------------------------------------

- Operating revenue $48.8B (+15.4% YoY); diluted GAAP EPS $9.61, adjusted diluted EPS $11.97.
- Benefit expense ratio 86.4% (+80 bps YoY); operating expense ratio 10.9% (-70 bps).
- Health Benefits segment op. revenue $41.4B, op. gain $2.2B; Carelon op. revenue $16.7B, op. gain $1.1B.
- Medical membership ~45.8M (+99K from year-end); returned $1.3B capital via buybacks & dividends.
- Reaffirmed FY 2025 adjusted diluted EPS guidance $34.15-$34.85; Q2 dividend $1.71/share declared.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/0001156039-25-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/elv-20250422.htm
  HTML page:      https://secwatch.observer/filing/0001156039-25-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer